FBLG · FibroBiologics, Inc. · Analyst Estimates
$1.18
-0.06 (-4.84%)
At close · Oct 5
Return incl. dividend (before tax)
Going-concern doubt
— flagged Jul 31, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company's ability to continue as a going concern for one year from the issuance of the condensed consolidated financial statements. While management has implemented plans to obtain additional funding, these plans are not sufficient to alleviate the substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Jul 31, 2026
Market Cap
$9.25M
Shares
6.66M
Volume · Oct 5
94.25K
Avg daily vol (3M)
197.33K
Analyst Estimates
Compare analyst forecasts for FibroBiologics, Inc. across metrics and forecast periods.
Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.
Compiled consensus
These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.
Captured 2026-09-18 04:09 UTC · Publication dates shown per estimate · 16 metric / period groups
FY ending 2026-12-31
| Metric | Low | Average | High | Analyst count | Average, 30 days ago | Average, 60 days ago | Average, 7 days ago | Average, 90 days ago | Estimates lowered, last 30 days | Estimates lowered, last 7 days | Estimates raised, last 30 days | Estimates raised, last 7 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
-3.0
|
-3.0
|
-3.0
|
— |
-4.01
|
-4.01
|
-4.01
|
-3.705
|
— | — | — | — |
|
EPS
analysts
Publication date not stated |
— | — | — |
1
|
— | — | — | — |
0
|
0
|
1
|
1
|
|
Revenue
USD
Publication date not stated |
0
|
0
|
0
|
— | — | — | — | — | — | — | — | — |
|
Revenue
analysts
Publication date not stated |
— | — | — |
3
|
— | — | — | — | — | — | — | — |
FY ending 2027-12-31
| Metric | Low | Average | High | Analyst count | Average, 30 days ago | Average, 60 days ago | Average, 7 days ago | Average, 90 days ago | Estimates lowered, last 30 days | Estimates lowered, last 7 days | Estimates raised, last 30 days | Estimates raised, last 7 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
-3.25
|
-3.25
|
-3.25
|
— |
-4.49
|
-4.49
|
-4.49
|
-3.845
|
— | — | — | — |
|
EPS
analysts
Publication date not stated |
— | — | — |
1
|
— | — | — | — |
0
|
0
|
1
|
1
|
|
Revenue
USD
Publication date not stated |
0
|
0
|
0
|
— | — | — | — | — | — | — | — | — |
|
Revenue
analysts
Publication date not stated |
— | — | — |
3
|
— | — | — | — | — | — | — | — |
Q ending 2026-09-30
| Metric | Low | Average | High | Analyst count | Average, 30 days ago | Average, 60 days ago | Average, 7 days ago | Average, 90 days ago | Estimates lowered, last 30 days | Estimates lowered, last 7 days | Estimates raised, last 30 days | Estimates raised, last 7 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
-0.63
|
-0.63
|
-0.63
|
— |
-0.94
|
-0.94
|
-0.94
|
-0.77
|
— | — | — | — |
|
EPS
analysts
Publication date not stated |
— | — | — |
1
|
— | — | — | — |
0
|
0
|
1
|
1
|
|
Revenue
USD
Publication date not stated |
0
|
0
|
0
|
— | — | — | — | — | — | — | — | — |
|
Revenue
analysts
Publication date not stated |
— | — | — |
3
|
— | — | — | — | — | — | — | — |
Q ending 2026-12-31
| Metric | Low | Average | High | Analyst count | Average, 30 days ago | Average, 60 days ago | Average, 7 days ago | Average, 90 days ago | Estimates lowered, last 30 days | Estimates lowered, last 7 days | Estimates raised, last 30 days | Estimates raised, last 7 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
-0.63
|
-0.63
|
-0.63
|
— |
-0.94
|
-0.94
|
-0.94
|
-0.87
|
— | — | — | — |
|
EPS
analysts
Publication date not stated |
— | — | — |
1
|
— | — | — | — |
0
|
0
|
1
|
1
|
|
Revenue
USD
Publication date not stated |
0
|
0
|
0
|
— | — | — | — | — | — | — | — | — |
|
Revenue
analysts
Publication date not stated |
— | — | — |
3
|
— | — | — | — | — | — | — | — |